Point-of-care diagnostic devices have transformed medical diagnostics and healthcare systems worldwide. Their critical importance, particularly in delivering rapid and accurate results, was underscored during the SARS-CoV-2 (COVID-19) pandemic.
Our laboratory is actively engaged in the development of advanced point-of-care devices for diagnosing both infectious and non-infectious diseases. Our research focuses on creating portable, cost-effective, plug-and-play diagnostic tools leveraging nucleic acid amplification techniques such as PCR and LAMP. This work has already led to the development of a low-cost, portable PCR/LAMP device capable of quantitative fluorescent output detection.
Expanding further, we recently initiated a new project aimed at developing wearable microfluidic devices that integrate Internet of Things (IoT) technologies with Artificial Intelligence (AI), opening new frontiers in personalized healthcare.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.